Immune-Modulating Fibroblast Therapy for Cachexia Inflammation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current interventions for cachexia, particularly in cancer patients, are ineffective due to the multifactorial nature of cancer-associated inflammation, leading to muscle wasting, metabolic abnormalities, and multiple organ failure.
Innovation Solution
Administration of immune-modulating fibroblasts, derived from amniotic fluid, which express specific markers and are capable of suppressing tumor-derived molecules inducing muscle atrophy and immune inhibition, administered via various routes to restore physiological and metabolic homeostasis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If inflammatory mediators are inhibited to treat cachexia, then muscle wasting should be reduced, but the multifactorial nature of cancer-associated inflammation makes interventions relatively ineffective
Solution Approach 1:
The patent uses fibroblasts as intermediary cells that modulate the complex inflammatory response. These fibroblasts act as mediators between the tumor microenvironment and the host immune system, producing cytokines and growth factors that regulate inflammation without simply blocking inflammatory mediators. This approach addresses the multifactorial nature of cancer-associated inflammation by introducing a biological agent that can respond to and regulate multiple inflammatory pathways simultaneously.
2Object-affected harmful factors
If tumor burden is reduced through current interventions, then cancer progression should be slowed, but pathologies associated with tumor mass impact on general physiology remain unaddressed
Solution Approach 1:
The fibroblasts described in the patent perform multiple functions: they modulate inflammation, protect muscle tissue from wasting, regulate metabolism, and support immune function. This multi-functionality addresses various physiological pathologies caused by tumor burden simultaneously, rather than targeting just tumor growth. The fibroblasts adapt to different pathological conditions and provide comprehensive support to affected organ systems.
3Reliability
If fibroblasts are administered to restore physiological homeostasis, then muscle wasting and inflammation should be reduced, but the complexity of culturing and administering these cells increases
Solution Approach 1:
The fibroblasts are cultured and conditioned in advance before administration to patients. This preliminary action allows the cells to be pre-differentiated, pre-loaded with therapeutic factors, and quality-tested before clinical use. The culturing process prepares the fibroblasts to immediately exert their therapeutic effects upon administration, reducing the need for complex in vivo manipulation and simplifying the overall treatment protocol.
Data Source
AI summary
Disclosed are methods and compositions related to treatment, amelioration or prevention of cachexia or inflammation related to cachexia in a subject. As disclosed, cachexia or inflammation related to cachexia can be treated, ameliorated or prevented by the administration of an effective amount of a composition including immune-modulating fibroblasts to the subject.